Nabriva Therapeutics AG (NBRV) PT Raised to $20 at Morgan Stanley
Tweet
Share
E-mailGet Alerts NBRV Hot Sheet
Price: $1.42 --0%
Rating Summary:
4 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Rating Summary:
4 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
Morgan Stanley analyst David Lebowitz raised the price target on Nabriva Therapeutics AG (NASDAQ: NBRV) to $20.00 (from $2.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Voltas Ltd. (VOLT:IN) PT Lowered to INR1,357 at Nomura/Instinet
- JD Health International Inc (6618:HK) PT Lowered to HK$60 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
